Ampliphi Biosciences Corp (NYSEAMERICAN:APHB – Get Free Report)’s share price crossed below its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $2.03 and traded as low as $1.98. Ampliphi Biosciences shares last traded at $1.99, with a volume of 8,496 shares.
Ampliphi Biosciences Trading Down 2.9 %
The business has a fifty day moving average price of $2.03.
Ampliphi Biosciences Company Profile
AmpliPhi Biosciences Corporation, a biotechnology company, focuses on the development of therapies for antibiotic-resistant infections using bacteriophage-based technology. The company is involved in developing AB-SA01 for the treatment of staphylococcus aureus (S. aureus) infections; and AB-PA01 for the treatment of pseudomonas aeruginosa (P.
Featured Articles
- Five stocks we like better than Ampliphi Biosciences
- Top Biotech Stocks: Exploring Innovation Opportunities
- Everything About Amazon Stock Signals a Buy—Time to Load Up?
- What is the Shanghai Stock Exchange Composite Index?
- 5 Reasons Five Below’s Stock Price Is Heading Higher This Year
- Why Invest in High-Yield Dividend Stocks?
- Broadcom: Why the Chip Stock Remains a Top Long-Term AI Play
Receive News & Ratings for Ampliphi Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampliphi Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.png?v=20240521153233&h=45&w=95&zc=2){kind=logo}
